47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,3 | 0,1 | -57,1 |
Gross profit (loss) | 0,5 | 0,3 | 0,1 | -67,8 |
EBITDA | 0,5 | 0,3 | -30,4 | |
Short time liabilities | 0,9 | 1,1 | 1,3 | 21,6 |
Other operating costs | 0 | 0 | 46,9 | |
Equity capital | 1,1 | 1,3 | 1,4 | 6 |
Operating profit (EBIT) | 0,5 | 0,3 | -32,1 | |
Assets | 2,2 | 2,5 | 2,8 | 12,7 |
Net profit (loss) | 0,4 | 0,3 | 0,1 | -69 |
Cash | 0,1 | 0,1 | 0,1 | 11,9 |
Liabilities and provisions for liabilities | 1,1 | 1,2 | 1,4 | 20,1 |
Net income from sale | 11 | 11,8 | 11,9 | 1,4 |
Working assets | 2,1 | 2,4 | 2,8 | 13,3 |
Other income costs | 0,2 | 0 | 0 | -100 |
Depreciation | 0 | 0 | 0 | -56,3 |
% | % | % | p.p. | |
Profitability of capital | 38,8 | 19,4 | 5,7 | -13,7 |
Equity capital to total assets | 48,1 | 52,4 | 49,3 | -3,1 |
Gross profit margin | 4,2 | 2,7 | 0,8 | -1,9 |
EBITDA Margin | 4,3 | 2,8 | -1,5 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 31 | 33 | 39 | 6 |
Current financial liquidity indicator | 2.2904040813446045 | 2.3017208576202393 | 2.145155906677246 | -0,2 |
Net dept to EBITDA | 0.23327864706516266 | 0.003542749909684062 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane